The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Preliminary product parameter and safety results from NeuACT, a phase 2 randomized, open-label trial of DN24-02 in patients with surgically resected HER2+ urothelial cancer at high risk for recurrence.
Dean F. Bajorin
Consultant or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Dendreon; Genentech; Novartis; Pfizer; Roche
Research Funding - Amgen; Dendreon; GlaxoSmithKline; Novartis; Pfizer
Leonard G. Gomella
Consultant or Advisory Role - Abbott Laboratories; Astellas Pharma; Bayer; Dendreon; Janssen
Honoraria - Dendreon
Research Funding - Astellas Pharma; Dendreon; Janssen
Padmanee Sharma
Consultant or Advisory Role - Bristol-Myers Squibb; Dendreon; Jounce Therapeutics; MedImmune
Stock Ownership - Jounce Therapeutics
Elizabeth R. Plimack
Consultant or Advisory Role - Dendreon
Research Funding - Dendreon
Peter H. O'Donnell
Honoraria - Dendreon
Jean H. Hoffman-Censits
No relevant relationships to disclose
Thomas W. Flaig
Employment or Leadership Position - Aurora Oncology (U)
Consultant or Advisory Role - GTx; Sanofi
Stock Ownership - Aurora Oncology
Honoraria - Amgen
Research Funding - Dendreon; Novartis; Sanofi
David I. Quinn
Consultant or Advisory Role - Algeta; Amgen; Astellas Pharma; AVEO; Bayer; Dendreon; Fresenius Biotech; Genentech; Janssen; Medivation; Nora Pharmaceuticals ; Pfizer; Prometheus
Honoraria - Algeta; Amgen; Astellas Pharma; AVEO; Bayer; Dendreon; Genentech; Janssen; Medivation; Novartis; Pfizer; Prometheus
Research Funding - Millennium; Sanofi
Expert Testimony - Medivation; Teva
Dwayne Campogan
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Heather Haynes
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Candice McCoy
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Johnathan Maher
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Todd DeVries
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Nadeem A. Sheikh
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Seth P. Lerner
Consultant or Advisory Role - Dendreon